Savvy Stock Picks

Repros Therapeutics Inc. (Public, NASDAQ:RPRX) decreased -4.42%, currently trading at $3.24 and its overall traded volume was 1.94M shares while reporting, against its average volume of 1.41M. RPRX opened the day at $3.48, it made an intraday low of $3.18 and an intraday high of $3.74. The stock has a 52 week low of $1.11 and 52 week high of $4.88. RPRX’s market capitalization is 28.93M and it has 8.93M outstanding shares.

About Repros Therapeutics Inc. (Public, NASDAQ:RPRX)

Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. Its product pipeline consists of Androxal and Proellex. Androxal (male reproductive health) completed Phase 2b proof-of-concept trial in men treated for low testosterone levels who want to improve or maintain their fertility and/or sperm number and function, and its Investigational New Drug Application (IND), for the study of oral Androxal in the treatment of hypogonadal men with type II diabetes was accepted by the United States Food and Drug Administration (FDA). Proellex is a female reproductive health. All clinical trial activities for Proellex have been put on hold by the FDA.

SanDisk Corporation (Public, NASDAQ:SNDK) decreased -0.70%, currently trading at $49.80 and its overall traded volume was 1.92M shares while reporting, against its average volume of 8.08M. SNDK opened the day at $50.25, it made an intraday low of $49.56 and an intraday high of $50.32. The stock has a 52 week low of $24.90 and 52 week high of $52.31. SNDK’s market capitalization is 11.68B and it has 234.50M outstanding shares.

About SanDisk Corporation (Public, NASDAQ:SNDK)

SanDisk Corporation (SanDisk) is engaged in designing, developing and manufacturing data storage solutions in a range of form factors using the flash memory, controller and firmware technologies. The Company’s solutions include removable cards, embedded products, universal serial bus (USB) drives, digital media players, wafers and components. The removable card products are used in a range of consumer electronics devices, such as mobile phones, digital cameras, gaming devices and laptop computers. Its embedded flash products are used in mobile phones, navigation devices, gaming systems, imaging devices and computing platforms. For computing platforms, it provides high-speed, high-capacity storage solutions known as solid-state drives (SSDs), that can be used in hard disk drives in a variety of computing devices.

MannKind Corporation (Public, NASDAQ:MNKD) decreased -2.07%, currently trading at $8.06 and its overall traded volume was 1.85M shares while reporting, against its average volume of 3.13M. MNKD opened the day at $8.20, it made an intraday low of $7.92 and an intraday high of $8.20. The stock has a 52 week low of $4.76 and 52 week high of $11.12. MNKD’s market capitalization is 1.01B and it has 124.77M outstanding shares.

About MannKind Corporation (Public, NASDAQ:MNKD)

MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The Company’s lead product candidate, AFREZZA (insulin human) Inhalation Powder, is insulin that has completed Phase III clinical trials. AFREZZA utilizes its Technosphere formulation technology, which is based on a class of organic molecules that are designed to self-assemble into small particles onto which drug molecules can be loaded. With AFREZZA, the Company loads recombinant human insulin onto the Technosphere particles, however, this technology is not limited to insulin delivery. In March 2009, the Company submitted a new drug application (NDA) to the United Stated Food and Drug Administration (FDA) for AFREZZA. In June 2009, it acquired a quantity of bulk insulin from Pfizer Manufacturing Frankfurt GmbH, a subsidiary of Pfizer Inc.

Amgen, Inc. (Public, NASDAQ:AMGN) increased 0.04%, currently trading at $55.98 and its overall traded volume was 1.74M shares while reporting, against its average volume of 7.12M. AMGN opened the day at $56.17, it made an intraday low of $55.92 and an intraday high of $56.37. The stock has a 52 week low of $50.26 and 52 week high of $61.26. AMGN’s market capitalization is 52.89B and it has 944.82M outstanding shares.

About Amgen, Inc. (Public, NASDAQ:AMGN)

Amgen Inc. (Amgen) is an independent biotechnology medicines company. The Company discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Its principal products include Aranesp (darbepoetin alfa) and EPOGEN (Epoetin alfa), erythropoietic-stimulating agents (ESAs) that stimulate the production of red blood cells; Neulasta (pegfilgrastim), a pegylated protein, based on the Filgrastim molecule, and NEUPOGEN (Filgrastim), a recombinant-methionyl human granulocyte colony-stimulating factor (G-CSF), both of which selectively stimulate the production of neutrophils (a type of white blood cell that helps the body fight infection), and Enbrel (etanercept), an inhibitor of tumor necrosis factor (TNF), a substance that plays a role in the body’s response to inflammatory diseases.

Atmel Corporation (Public, NASDAQ:ATML) decreased -0.08%, currently trading at $12.27 and its overall traded volume was 1.73M shares while reporting, against its average volume of 10.52M. ATML opened the day at $12.27, it made an intraday low of $12.13 and an intraday high of $12.28. The stock has a 52 week low of $4.29 and 52 week high of $12.68. ATML’s market capitalization is 5.62B and it has 458.29M outstanding shares.

About Atmel Corporation (Public, NASDAQ:ATML)

Atmel Corporation designs, develops, manufacture and sells a range of semiconductor integrated circuit (IC) products and touch solutions. Its products consist primarily of microcontrollers, advanced logic, mixed-signal, nonvolatile memory, radio frequency (RF) and system-level integration semiconductor solutions. The Company operates in four segments: Microcontrollers, Nonvolatile Memories, RF and Application specific integrated circuit (ASIC). The Company supplies its customers with solutions incorporating microcontrollers. These system-on-a-chip solutions are manufactured using its process technologies, including complementary metal oxide semiconductor (CMOS), double-diffused metal oxide semiconductor (DMOS), logic, CMOS logic, bipolar, bipolar CMOS (BiCMOS), silicon germanium (SiGe), SiGe BiCMOS, analog, bipolar double diffused CMOS and radiation technologies.